Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00057642 · ClinicalTrials.gov registry record · NA

Improving Retention of Hispanics Receiving Antidepressant Therapy

A NA study of Depression and Depressive Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT00057642 is a NA study of Depression and Depressive Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 50 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00057642, a NA study of Depression and Depressive Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will develop an intervention that will increase the retention of Hispanics with major depression in antidepressant therapy.

Interventions

  • DRUG Sertraline
  • DRUG Venlafaxine Extended Release

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2002-09
Est. Completion 2006-08
Phase NA

What the Registry Record Tells You About NCT00057642

The ClinicalTrials.gov registry entry for NCT00057642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Sertraline is the first listed.

NCT00057642 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00057642 about?

NCT00057642 is a clinical study titled "Improving Retention of Hispanics Receiving Antidepressant Therapy". This study will develop an intervention that will increase the retention of Hispanics with major depression in antidepressant therapy.

What is the current status of trial NCT00057642?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2006-08.

What conditions does trial NCT00057642 study?

This clinical trial studies the following conditions: Depression, Depressive Disorder.

What interventions are being tested in trial NCT00057642?

The interventions under investigation include: Sertraline (DRUG), Venlafaxine Extended Release (DRUG).

Who is sponsoring clinical trial NCT00057642?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00057642 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.